About Geospiza
Geospiza is a company based in Seattle (United States) founded in 1997 was acquired by PerkinElmer in May 2011. Geospiza has raised $4.85 million across 6 funding rounds from investors including HHS and PerkinElmer. Geospiza operates in a competitive market with competitors including Depixus, Genomics, Seven Bridges Genomics, Hexagon Bio and BC Platforms, among others.
- Headquarter Seattle, United States
- SectorsHealthcare
- Website geospiza.com
- Social LinkedIn
- Acquired by PerkinElmer (May 2011)
- Total Equity Funding$4.85 M (USD)
in 6 rounds
- Latest Funding Round$1.17 M (USD), Grant
Dec 28, 2010
- InvestorsHHS
& 1 more
- Acquired byPerkinElmer
(May 05, 2011)
Funding Insights of Geospiza
Geospiza has successfully raised a total of $4.85M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $1.17 million completed in December 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.8M
- Total Rounds 6
- Last Round Grant — $1.2M
- First Round $1.0M
(02 May 2005)
- Investors Count 1
All 6 funding rounds of Geospiza with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Geospiza
Geospiza has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and PerkinElmer.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - | |
Medical instruments and supplies are manufactured and provided for healthcare. | 1931 | perkinelmer.com | Waltham, United States |
Investor details for Geospiza
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Geospiza
4 dated milestones of Geospiza across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Geospiza is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant, of $1.2M.
- Exit Acquired by PerkinElmer.
Competitors of Geospiza
Geospiza operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Depixus, Genomics, Seven Bridges Genomics, Hexagon Bio and BC Platforms, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| depixus.com | 2012 | Paris, France | $34.5M | – | Single-molecule genetic and epigenetic sequencing solutions are provided. | |
| genomics.com | 2014 | Oxford, United Kingdom | $115.5M | – | Genomic risk assessment and prevention platform is provided. | |
| sevenbridges.com | 2009 | Cambridge, United States | $113.0M | 112 | Cloud-based platform to analyze, store, and act on genomic data. | |
| hexagonbio.com | 2017 | Menlo Park, United States | $205.6M | 34 | Bioinformatics tools are provided for analyzing microbial genomic sequencing data. | |
| bcplatforms.com | 1997 | Zurich, Switzerland | $47.1M | 8 | Platforms for genomic data analysis and management are provided. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. | |
| deepgenomics.com | 2015 | Toronto, Canada | $238.0M | – | Machine learning is utilized for precision medicine and genetic diagnostics. | |
| envisagenics.com | 2014 | Long Island, United States | $46.8M | – | RNA splicing therapeutics are discovered and developed through AI-driven biotechnology. | |
| eaglegenomics.com | 2008 | Cambridge, United Kingdom | $38.7M | – | Developer of cloud-based software solutions for genomic analysis | |
| seqone.com | 2017 | Montpellier, France | $48.8M | – | Bioinformatics tools for genome sequencing data analysis are provided. |
Detailed competitors of Geospiza
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Geospiza
10 companies that operate in the same segment as Geospiza (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Geospiza
Geospiza was founded in 1997 and raised its 1st funding round 8 years after it was founded.
Geospiza is headquartered in Seattle, United States. It is registered at Seattle, Washington, United States.
Geospiza is a funded company, having raised a total of $4.85M across 6 funding rounds to date. The company's 1st funding round was a Unspecified of $1M, raised on May 02, 2005.
Geospiza was founded in 1997 in Seattle, United States, focusing on enterprise software for genetic analysis workflow management. Products such as GeneSifter Analysis Edition for sequencing and GeneSifter Lab Edition for lab operations are offered. These tools support clinical DNA testing, biotherapeutic manufacturing, and contract lab services. Customers include biotechnology firms, pharmaceutical companies, universities, and research institutes. Acquisition by PerkinElmer occurred in 2011.
Geospiza's top competitors include Eagle Genomics, Depixus and Ingenuity Systems.
Geospiza has 2 investors. Key investors include HHS, and PerkinElmer.
Yes. Geospiza was acquired by PerkinElmer in May 2011.